Senti Biosciences, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-20.3% -$2M
$-14M
Free Cash Flow↑+100.0% +$11K
$0
Investing Cash Flow
$0
Financing Cash Flow↓-78.5% -$40M
$11M
Capex↓-100.0% -$11K
$0
Stock-Based Comp↑+135.5% +$820K
$1M
D&A↓-4.7% -$44K
$893K
SBC Allocated Expense↑+135.5% +$820K
$1M
SBC Unrecognized Cost
—